| Riverpark Eyecare Pllc | |
|
221 Allen St, Owensboro, KY 42303-4139 | |
| (270) 685-4966 | |
| (270) 686-8058 |
| Full Name | Riverpark Eyecare Pllc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 221 Allen St, Owensboro, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508995895 | NPI | - | NPPES |
| 77900629 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| Provider Name | Robert Alan Hamilton |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1669471843 PECOS PAC ID: 1658273594 Enrollment ID: I20040122000370 |
News Archive
In recent years, RNA molecules, with the ability to affect or turn off pathogenic genes, have become promising drug candidates in several areas.
White, brown and beige adipocytes, or fat cells, are inherently different. Each of these cell types has different functions and each plays its own role in metabolism. In the human body, white adipose tissue is by far the most prevalent.
EpiCept Corporation today announced that it has reached an agreement on all outstanding issues with the U.S. Food and Drug Administration (FDA) on a regulatory path forward for Ceplene® (histamine dihydrochloride), the Company's lead product for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first complete remission. Ceplene® is approved in the European Union for this indication and is marketed there by Meda AB.
Scientists have developed a new method to clear antibiotic resistant bacteria from the surface of the eye – introducing a new strain of bacteria that preys on other microorganisms.
Children who suffer from acute asthma attacks share a genetic profile that appears to be unique to these children, according to a new study by researchers at Cincinnati Children's Hospital Medical Center. The discovery opens the door to the possibility of designing treatments specifically tailored to children who suffer from the severest forms of asthma.
› Verified 7 days ago
| Provider Name | Michael S Shields |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1609875848 PECOS PAC ID: 5698677524 Enrollment ID: I20101207000619 |
News Archive
In recent years, RNA molecules, with the ability to affect or turn off pathogenic genes, have become promising drug candidates in several areas.
White, brown and beige adipocytes, or fat cells, are inherently different. Each of these cell types has different functions and each plays its own role in metabolism. In the human body, white adipose tissue is by far the most prevalent.
EpiCept Corporation today announced that it has reached an agreement on all outstanding issues with the U.S. Food and Drug Administration (FDA) on a regulatory path forward for Ceplene® (histamine dihydrochloride), the Company's lead product for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first complete remission. Ceplene® is approved in the European Union for this indication and is marketed there by Meda AB.
Scientists have developed a new method to clear antibiotic resistant bacteria from the surface of the eye – introducing a new strain of bacteria that preys on other microorganisms.
Children who suffer from acute asthma attacks share a genetic profile that appears to be unique to these children, according to a new study by researchers at Cincinnati Children's Hospital Medical Center. The discovery opens the door to the possibility of designing treatments specifically tailored to children who suffer from the severest forms of asthma.
› Verified 7 days ago
| Provider Name | Elizabeth Mauzy Martin |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1083969034 PECOS PAC ID: 6709042146 Enrollment ID: I20120730000366 |
News Archive
In recent years, RNA molecules, with the ability to affect or turn off pathogenic genes, have become promising drug candidates in several areas.
White, brown and beige adipocytes, or fat cells, are inherently different. Each of these cell types has different functions and each plays its own role in metabolism. In the human body, white adipose tissue is by far the most prevalent.
EpiCept Corporation today announced that it has reached an agreement on all outstanding issues with the U.S. Food and Drug Administration (FDA) on a regulatory path forward for Ceplene® (histamine dihydrochloride), the Company's lead product for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first complete remission. Ceplene® is approved in the European Union for this indication and is marketed there by Meda AB.
Scientists have developed a new method to clear antibiotic resistant bacteria from the surface of the eye – introducing a new strain of bacteria that preys on other microorganisms.
Children who suffer from acute asthma attacks share a genetic profile that appears to be unique to these children, according to a new study by researchers at Cincinnati Children's Hospital Medical Center. The discovery opens the door to the possibility of designing treatments specifically tailored to children who suffer from the severest forms of asthma.
› Verified 7 days ago
| Provider Name | Haleigh E Stringer |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1063039451 PECOS PAC ID: 9739503269 Enrollment ID: I20200716003284 |
News Archive
In recent years, RNA molecules, with the ability to affect or turn off pathogenic genes, have become promising drug candidates in several areas.
White, brown and beige adipocytes, or fat cells, are inherently different. Each of these cell types has different functions and each plays its own role in metabolism. In the human body, white adipose tissue is by far the most prevalent.
EpiCept Corporation today announced that it has reached an agreement on all outstanding issues with the U.S. Food and Drug Administration (FDA) on a regulatory path forward for Ceplene® (histamine dihydrochloride), the Company's lead product for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first complete remission. Ceplene® is approved in the European Union for this indication and is marketed there by Meda AB.
Scientists have developed a new method to clear antibiotic resistant bacteria from the surface of the eye – introducing a new strain of bacteria that preys on other microorganisms.
Children who suffer from acute asthma attacks share a genetic profile that appears to be unique to these children, according to a new study by researchers at Cincinnati Children's Hospital Medical Center. The discovery opens the door to the possibility of designing treatments specifically tailored to children who suffer from the severest forms of asthma.
› Verified 7 days ago
| Provider Name | Elizabeth Ann Richardson |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1285310029 PECOS PAC ID: 3870955230 Enrollment ID: I20230816003333 |
News Archive
In recent years, RNA molecules, with the ability to affect or turn off pathogenic genes, have become promising drug candidates in several areas.
White, brown and beige adipocytes, or fat cells, are inherently different. Each of these cell types has different functions and each plays its own role in metabolism. In the human body, white adipose tissue is by far the most prevalent.
EpiCept Corporation today announced that it has reached an agreement on all outstanding issues with the U.S. Food and Drug Administration (FDA) on a regulatory path forward for Ceplene® (histamine dihydrochloride), the Company's lead product for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first complete remission. Ceplene® is approved in the European Union for this indication and is marketed there by Meda AB.
Scientists have developed a new method to clear antibiotic resistant bacteria from the surface of the eye – introducing a new strain of bacteria that preys on other microorganisms.
Children who suffer from acute asthma attacks share a genetic profile that appears to be unique to these children, according to a new study by researchers at Cincinnati Children's Hospital Medical Center. The discovery opens the door to the possibility of designing treatments specifically tailored to children who suffer from the severest forms of asthma.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Riverpark Eyecare Pllc 221 Allen St, Owensboro, KY 42303-4139 Ph: (270) 685-4966 | Riverpark Eyecare Pllc 221 Allen St, Owensboro, KY 42303-4139 Ph: (270) 685-4966 |
News Archive
In recent years, RNA molecules, with the ability to affect or turn off pathogenic genes, have become promising drug candidates in several areas.
White, brown and beige adipocytes, or fat cells, are inherently different. Each of these cell types has different functions and each plays its own role in metabolism. In the human body, white adipose tissue is by far the most prevalent.
EpiCept Corporation today announced that it has reached an agreement on all outstanding issues with the U.S. Food and Drug Administration (FDA) on a regulatory path forward for Ceplene® (histamine dihydrochloride), the Company's lead product for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first complete remission. Ceplene® is approved in the European Union for this indication and is marketed there by Meda AB.
Scientists have developed a new method to clear antibiotic resistant bacteria from the surface of the eye – introducing a new strain of bacteria that preys on other microorganisms.
Children who suffer from acute asthma attacks share a genetic profile that appears to be unique to these children, according to a new study by researchers at Cincinnati Children's Hospital Medical Center. The discovery opens the door to the possibility of designing treatments specifically tailored to children who suffer from the severest forms of asthma.
› Verified 7 days ago
Dr. Kaitlin Breanne Nesty, OD Optometrist Medicare: Medicare Enrolled Practice Location: 3310 Professional Park Ste 101, Owensboro, KY 42303 Phone: 270-683-2101 Fax: 270-683-2507 | |
Taylor Gaddis Brewer, Optometrist Medicare: May Accept Medicare Assignments Practice Location: 1705 Frederica St, Owensboro, KY 42301 Phone: 270-683-2122 | |
Family First Vision Care Kentucky, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5035 Frederica St, Owensboro, KY 42301 Phone: 270-688-8811 | |
Haleigh Stringer, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 2905 New Hartford Rd, Owensboro, KY 42303 Phone: 270-685-4966 Fax: 270-686-8058 | |
Dr Joe Terry And Associates, Inc Optometrist Medicare: Medicare Enrolled Practice Location: 5040 Frederica St Ste A, Owensboro, KY 42301 Phone: 270-685-0247 Fax: 270-713-7932 | |
Elizabeth Mauzy Martin, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 221 Allen St, Owensboro, KY 42303 Phone: 270-685-4966 Fax: 270-686-8058 | |
Jaki Richter, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 411 Park Plaza Dr, Owensboro, KY 42301 Phone: 270-683-2020 |